Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia

Uzun, Omrum, Ascioglu, Sibel, Anaissie, Elias J., Rex, John H.·2001·Clinical Infectious Diseases
DOI 10.1086/320757

Cited by (138)

Items 101–138 of 138

  1. Disseminate Fungal Infection after Acute Pancreatitis in a Simultaneous Pancreas-Kidney Recipient
    Anna Rossetto, Umberto Baccarani, Dario Lorenzin, Andrea Risaliti, Pierluigi Viale, Vittorio Bresàdola, Gian Luigi Adani · 2010 · Journal of Transplantation
  2. Epidemiology and Outcomes of Candidaemia among Adult Patients Admitted at Hospital Universiti Sains Malaysia (HUSM): A 5-Year Review
    A Haydar · 2018 · IIUM Medical Journal Malaysia
  3. Los aspectos epidemiológicos cambiantes de la candidemia y sus implicaciones clinicoterapéuticas
    Miguel Salavert, Isidro Jarque Ramos, Javier Pemán · 2006 · Enfermedades Infecciosas y Microbiología Clínica
  4. Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia
    Letícia Kraft, Victoria Stadler Tasca Ribeiro, Geiziane Aparecida Gonçalves, Paula Hansen Suss, Felipe Francisco Tuon · 2022 · Enfermedades Infecciosas y Microbiología Clínica
  5. Modified Colorimetric Assay for Susceptibility Testing of Azole Antifungal Drugs against Candida Species
    Jian Chen, Zhe Wan, Ruoyu Li · 2004 · Journal of Clinical Microbiology
  6. Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016‐B survey
    Maria Ilaria Del Principe, Giulia Dragonetti, Allegra Conti, Luisa Verga, Stelvio Ballanti, Rosa Fanci, Anna Candoni, Francesco Marchesi, Chiara M. Cattaneo, Federica Lessi et al. · 2021 · Mycoses
  7. Les antifongiques dans le traitement des infections invasives
    Sylvie Carle · 2003 · Pharmactuel
  8. Intraabdominelle Pilzinfektionen
    Carsten Boos, P. Kujath, H.-P. Bruch · 2005 · Mycoses
  9. Can antibiotics affect the clinical features of patients with candidemia? The retrospective evaluation of 5 years of data in an intensive care unit
    Mefküre Durmuş, Serkan Kalkan, Sena Güzel Karahan, Murat Bıçakcıoğlu, Nesligül Özdemir, Zeynep Ülkü GÜN, Ayşe Belin Özer · 2023 · European Journal of Hospital Pharmacy
  10. Mortality Associated with Breakthrough Candidemia among Patients with and Those without Cancer
    Vladimir Krcmery, Robert Babela · 2002 · Clinical Infectious Diseases
  11. Disseminated Candidiasis Developing during Prophylaxis with Fluconazole in a Small-Intestine Transplant Recipient
    Şükran Köse, Melda Türken, Gülgün Akkoçlu, Cezmi Karaca, Süheyla Serin Senger · 2012 · Progress in Transplantation
  12. Candidalysin promotes fungal-specific Th17 CD4 T cell differentiation and protective systemic immunogenicity
    Ngan N. M. Nguyen, Alexander E. Brady, David B Haslam, Corey Frazer, Giang H. Pham, Richard J. Bennett, Sing Sing Way · 2026 · Mucosal Immunology
  13. Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common Candida Species: A Propensity Score Matching Analysis
    Jong Hun Kim, Jin Woong Suh, Min Ja Kim · 2023 · Journal of Fungi
  14. Fungal Infections in Neutropenic Patients
    Juan Gea‐Banacloche, Andreas H. Groll, Thomas J. Walsh · 2010 · Springer eBooks
  15. Oral Candidiasis amongst cancer patients at Qods Hospital
    Enayatollah Kalantar, SH Afraseyabi, A Afkhamzadeh, H Sabori, F. Verdi, Nabuwat Khaksar, B Mosavei · 2011 · African Journal of Clinical and Experimental Microbiology
  16. Infectious Emergencies in Dermatology
    Emily F. Stamell, Karthik Krishnamurthy · 2012 · Springer eBooks
  17. Epidemiology and Management of Candidiasis in Solid Organ Transplant Recipients
    Ahmed Al Hammadi, Luis L. Ostrosky-Zeichner · 2016 · Current Fungal Infection Reports
  18. Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia
    Letícia Kraft, Victoria Stadler Tasca Ribeiro, Geiziane Aparecida Gonçalves, Paula Hansen Suss, Felipe Francisco Tuon · 2023 · Enfermedades infecciosas y microbiologia clinica (English ed )
  19. Risk Factors and Prognosis for Persistent Candidemia without Catheter Colonization
    Yun Tae Chae, Su Jin Jeong, Nam Su Ku, Ji Hyeon Baek, Hyewon Kim, Sun Bean Kim, Ji Hyun Yoon, Sung Joon Jin, Sang Hoon Han, Young Goo Song et al. · 2011 · Infection and Chemotherapy
  20. Methods Related to the Immunopathogenesis of Vulvovaginal Candidiasis and Associated Neutrophil Anergy
    Junko Yano, Paul L. Fidel · 2022 · Methods in molecular biology
  21. Reply
    Ömrüm Uzun, Sibel Aşçıoğlu, Elias J. Anaissie, J. H. Rex · 2002 · Clinical Infectious Diseases
  22. Candida spp. suppress neutrophil reactive nitrogen species to evade killing
    Thomas B. Burgess, Ffion R Hammond, Piotr T. Szkuta, Amy Lewis, Stella Christou, Kieran A Bowden, Tihana Bicanic, Lynne R. Prince, Kathryn R. Ayscough, David George Partridge et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Colonização por Candida em indivíduos com candidemia
    Lourdes das Neves Miranda · 2008
  24. Mortality, Hospital Stay, and Costs Associated With Candidemia After Major Esophagus, Stomach, and Bowel Procedures in US Hospitals
    Craig A. Wood, Srini Rajagopalan, Malathi Shivaprakash, Sheenu Chandwani, Robin S. Turpin · 2009 · Infectious Diseases in Clinical Practice
  25. Candidachorioretinitis and endophthalmitis
    Adam T. Gerstenblith, Chirag P. Shah · 2009 · Expert Review of Ophthalmology
  26. In-vitro Susceptibility of Candida Pathogens Isolated From Clinical Specimens to Available Antifungal Agents in Nigeria
    David Olusoga Ogbolu, Oyebode Armstrong Terry Alli, O. O. Adewumi, Adeolu Sunday Oluremi · 2015 · International Journal of TROPICAL DISEASE & Health
  27. Risk factors in a patient with fungemia caused by fluconazole-resistant Candida albicans
    Ayşe Demet Kaya, Muhterem Yücel, İstemi Yücel · 2008 · Open Medicine
  28. Pathological Studies on Experimental Systemic Candidiasis induced by Candida albicans Isolated from Different Animals in Immunosuppressed Mice
    Nahla Ag, Ahmed Refat · 2011
  29. Survival time from diagnosis of candidemia: An application of survival methods for epidemiology to the Mycoses Study Group multi-center observational study of hospitalized patients with candidemia
    Nicola D. Thompson · 2005 · OhioLink ETD Center (Ohio Library and Information Network)
  30. Distribuição de espécies, perfil de suscetibilidades ao fluconazol e fatores de risco para candidemia no Hospital de Clínicas de Porto Alegre
    Valério Rodrigues Aquino · 2005 · Americanae (AECID Library)
  31. CONCISE AR T ICLE
    Márcio Nucci · 2002
  32. Vaccines and Passive Immunity against Candidiasis
    B. Spellberg, Yue Fu, A. Ibrahim · 2012 · ASM Press eBooks
  33. Diagnosis and Treatment Challenges of Candida guilliermondii in Immunocompromised Patients: A Case Study in a Neutropenic AML Patient
    Dhruvi Modi, Sophie Dessureault, John Patrick Greene · 2024 · Case Reports in Infectious Diseases
  34. Lower respiratory tract C. albicans induces lung injury in mice and associates with worse lung injury endpoints in humans
    Nathanial J. Tolman, Wonseok Choi, Jonathan K. Alder, Mohammadreza Tabary, Shulin Qin, Xiaohong Wang, Yingze Zhang, Yizeng Tu, Lokesh Sharma, Jessica M. Bon et al. · 2024 · medRxiv
  35. Epidemiologia das infecções por Candida spp. na corrente sanguínea : coorte retrospectiva em hospital terciário brasileiro
    Alessandro Comarú Pasqualotto · 2004 · Americanae (AECID Library)
  36. Prognostic stratification in cancer candidemia under routine infectious disease consultation: Palliative Prognostic Index identifies patients with favorable short-term outcomes
    Noritaka Sekiya, Koh Okamoto, Kazuaki Fukushima, Tomohiro Hosoda, Kunihiko Takahashi, Yoshiaki Gu · 2025 · International Journal of Infectious Diseases
  37. Candida spp. suppress neutrophil reactive nitrogen species to evade killing
    Thomas B. Burgess, Ffion R Hammond, Piotr T. Szkuta, Amy Lewis, Stella Christou, Keiran A. Bowden, Tihana A. Bicanic, Lynne R. Prince, Kathryn R. Ayscough, David George Partridge et al. · 2026 · mBio
  38. Breakthrough candidemia during prophylactic or empirical antifungal therapy: antifungal exposure, in vitro activity, and association of early treatment modification with mortality
    Pedro Suárez-Urquiza, Marcos Velasco-Marrodán, Patricio Favier, Juan Frasquet, María Ángeles-Ferre, Ignacio Moreno, María Tasias, Eva Calabuig-Muñoz, Mónica Gordon-Sahuquillo, Javier Pemán et al. · 2026 · Expert Review of Anti-infective Therapy